HPV vaccine shows promise in cutting cervical lesion risk for HIV-Positive women
NCT ID NCT03284866
First seen Jan 30, 2026 · Last updated Jun 18, 2026 · Updated 17 times
Summary
This study looked at whether the HPV vaccine can help prevent high-grade cervical lesions (precancerous growths) in women living with HIV who were already being treated for HPV. About 536 women took part, receiving either the HPV vaccine or a placebo. The goal was to see if the vaccine could lower the chance of these lesions coming back or developing into cancer. Results suggest the vaccine may offer extra protection beyond standard treatment.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HIV INFECTION are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
African Cancer Institute at Stellenbosch
Cape Town, South Africa
-
Moi University School of Medicine
Eldoret, Kenya
-
UNC Project Malawi
Lilongwe, Malawi
-
Uganda Cancer Institute
Kampala, Uganda
-
University of Zimbabwe
Harare, Zimbabwe
-
University of the Witwatersrand
Johannesburg, South Africa
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.